Insufficiency of quality of life as the treatment endpoint for balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension.
Juanni GongYuan DingJianfeng WangWei WangQiang HuangRan MiaoTuguang KuangSuqiao YangJifeng LiXiaojing JiaoYuan-Hua YangPublished in: Journal of translational internal medicine (2024)
QoL is a useful tool for assessing the exercise endurance of patients with inoperable CTEPH treated with BPA, but is insufficient to serve as a treatment endpoint for BPA.